AzTrials
AzTrials

Virtual RealityReminiSOMMENCT06960915

Efficacy of Virtual Reality Reminiscence Therapy in Nursing Home Residents With Alzheimer's Disease or Related Diseases

A study testing immersive virtual reality and classic reminiscence workshops in people with Virtual Reality and Reminiscence Therapy, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This project provides the easiest possible access to heritage elements that older persons with Alzheimer's disease or related diseases knew well but to which they no longer have access due to the motor and functional dependencies they present. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
immersive virtual reality and classic reminiscence workshops
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteFrance
Study dates
10 Oct 2025to Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Residents of the long-term care facilities of the Amiens-Picardie University Hospital,
  • Residents with mild to moderate Alzheimer's disease or related diseases, i.e. with an MMSE ≥ 10,
  • Residents or their legal representative agreeing to participate in the study.

Who cannot join

  • Non-residents of the long-term care facilities of the Amiens-Picardie University Hospital,
  • Residents with an MMS < 10,
  • Residents or their legal representative refusing to participate in the study,
  • Residents in terminal palliative care,
  • Residents with disruptive behavioral disorders.

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHRU Amiens

    Amiens, 80480

Other trials in France

About this study

This project provides the easiest possible access to heritage elements that older persons with Alzheimer's disease or related diseases knew well but to which they no longer have access due to the motor and functional dependencies they present. It will strengthen the possibilities of reminiscence by using, rather than the usual supports, virtual reality technology to reinforce the immersion effect. It will involve carrying out virtual reality reminiscence workshops intended for residents in nursing home with Alzheimer's disease or related diseases and allowing them to explore the heritage of towns and villages in the Somme region thanks to these innovative solutions. The aim of this project is to reduce behavioral disorders and improve their quality of life.

Being tested
immersive virtual reality, classic reminiscence workshops
Keywords
Virtual reality, Reminiscence therapy, Nursing home, Alzheimer&#39;s disease or related diseases, crossover study

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • immersive virtual realityDevice

    The research procedure will be the realization of reminiscence workshops in immersive virtual reality. The residents will be equipped with a virtual reality headset where they will enjoy 360° panoramas that will immerse them in the heart of villages in the Amiens basin and in particular their village based on 3 to 5 images per village: church square, village square, town hall, emblematic places, etc.

  • classic reminiscence workshopsDevice

    It will be compared to classic reminiscence workshops in which the organizer will propose to discuss memories and past experiences using photographs, objects or music in the control arm.

Study groups in NCT06960915
Study groupRoleWhat they receive
immersive virtual realityExperimentalThe residents will be equipped with a virtual reality headset where they will enjoy 360° panoramas that will immerse them in the heart of villages in the Amiens basin and in particular their village based on 3 to 5 images per village: church square, village square, town hall, emblematic places, etc
Receives: Device: immersive virtual reality
classic reminiscence workshopsActive comparatorclassic reminiscence workshops in which the organizer will propose to discuss memories and past experiences using photographs, objects or music in the control arm
Receives: Device: classic reminiscence workshops

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reduced behavioral problem frequency in immersive virtual reality group

    Efficacy in reducing behavioral problems will be assessed using the sum of scores on the NPI-ES anxiety, depression, and apathy subscales.

    Measured: 1 year

Secondary outcomes (1)
  1. Improved quality of life in the immersive virtual reality group

    improving the quality of life will be assessed using a quality of life scale developed for patients with Alzheimer's disease or related diseases, the QOL-AD scale validated in French.

    The QOL-AD is administered in interview format to individuals with dementia, following the instructions below.

    Scoring instructions for QOL-AD:

    Points are assigned to each item as follows: poor = 1, fair = 2, good = 3, excellent = 4.

    The total score is the sum of all 13 items.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 May 2025
  2. Study start10 Oct 2025
  3. Primary completionNov 2026 (estimated)
  4. Study completionMar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06960915
Sponsor's protocol ID
PI2025_843_0068
Acronym
ReminiSOMME
Status last verified
Feb 2026
First submitted
29 Apr 2025
Last updated
11 Feb 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing immersive virtual reality and classic reminiscence workshops in people with Virtual Reality and Reminiscence Therapy, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 11 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reduced behavioral problem frequency in immersive virtual reality group (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in